BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24446291)

  • 1. Identifying differentially expressed genes and pathways in two types of non-small cell lung cancer: adenocarcinoma and squamous cell carcinoma.
    Liu J; Yang XY; Shi WJ
    Genet Mol Res; 2014 Jan; 13(1):95-102. PubMed ID: 24446291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
    Lu C; Chen H; Shan Z; Yang L
    Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bicluster and regulatory network analysis of differentially expressed genes in adenocarcinoma and squamous cell carcinoma.
    Li L; Zhu J; Guo SX; Deng Y
    Genet Mol Res; 2013 May; 12(2):1710-9. PubMed ID: 23765977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Molecular Mechanisms Analysis of Three Lung Cancer Subtypes Based on Gene Expression Profiles.
    Wang L; Pei Y; Li S; Zhang S; Yang Y
    J Comput Biol; 2019 Oct; 26(10):1140-1155. PubMed ID: 31305128
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatics analysis reveals disturbance mechanism of MAPK signaling pathway and cell cycle in Glioblastoma multiforme.
    Li W; Li K; Zhao L; Zou H
    Gene; 2014 Sep; 547(2):346-50. PubMed ID: 24967941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
    Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
    Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Key Transcription Factors Associated with Lung Squamous Cell Carcinoma.
    Zhang F; Chen X; Wei K; Liu D; Xu X; Zhang X; Shi H
    Med Sci Monit; 2017 Jan; 23():172-206. PubMed ID: 28081052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression in human non-small cell lung cancer: a systematic database.
    Bührens RI; Amelung JT; Reymond MA; Beshay M
    Pathobiology; 2009; 76(6):277-85. PubMed ID: 19955839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non small cell lung cancer gene expression profiles by cDNA microarrays].
    Ouyang QC; Hu CP; Shi LJ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):9-12. PubMed ID: 12934383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
    Sun Z; Wigle DA; Yang P
    J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
    Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
    Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
    Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
    Crowe DL; Shuler CF
    Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identified differently expressed genes in renal cell carcinoma by using multiple microarray datasets running head: differently expressed genes in renal cell carcinoma.
    Cheng Y; Hong M; Cheng B
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1033-40. PubMed ID: 24763884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.
    Dobashi Y; Jiang SX; Shoji M; Morinaga S; Kameya T
    J Pathol; 2003 Feb; 199(2):208-20. PubMed ID: 12533834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.
    Mao Y; Wu J; Skog S; Eriksson S; Zhao Y; Zhou J; He Q
    Oncol Rep; 2005 May; 13(5):837-46. PubMed ID: 15809747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway deviation-based biomarker and multi-effect target identification in asbestos-related squamous cell carcinoma of the lung.
    Du J; Zhang L
    Int J Mol Med; 2017 Mar; 39(3):579-586. PubMed ID: 28204826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
    Wei Y; Tong J; Taylor P; Strumpf D; Ignatchenko V; Pham NA; Yanagawa N; Liu G; Jurisica I; Shepherd FA; Tsao MS; Kislinger T; Moran MF
    J Proteome Res; 2011 Jan; 10(1):161-74. PubMed ID: 20815376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.